346 related articles for article (PubMed ID: 15520209)
1. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts.
Chen X; Conti PS; Moats RA
Cancer Res; 2004 Nov; 64(21):8009-14. PubMed ID: 15520209
[TBL] [Abstract][Full Text] [Related]
2. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model.
Hsu AR; Hou LC; Veeravagu A; Greve JM; Vogel H; Tse V; Chen X
Mol Imaging Biol; 2006; 8(6):315-23. PubMed ID: 17053862
[TBL] [Abstract][Full Text] [Related]
3. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
4. Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice.
Cheng Z; Wu Y; Xiong Z; Gambhir SS; Chen X
Bioconjug Chem; 2005; 16(6):1433-41. PubMed ID: 16287239
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopically well-characterized RGD optical probe as a prerequisite for lifetime-gated tumor imaging.
Mathejczyk JE; Pauli J; Dullin C; Napp J; Tietze LF; Kessler H; Resch-Genger U; Alves F
Mol Imaging; 2011 Dec; 10(6):469-80. PubMed ID: 22201538
[TBL] [Abstract][Full Text] [Related]
6. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
[TBL] [Abstract][Full Text] [Related]
7. Fast clearing RGD-based near-infrared fluorescent probes for in vivo tumor diagnosis.
Cao J; Wan S; Tian J; Li S; Deng D; Qian Z; Gu Y
Contrast Media Mol Imaging; 2012; 7(4):390-402. PubMed ID: 22649045
[TBL] [Abstract][Full Text] [Related]
8. Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers.
Liu Z; Liu S; Niu G; Wang F; Liu S; Chen X
Mol Imaging; 2010 Feb; 9(1):21-9. PubMed ID: 20128995
[TBL] [Abstract][Full Text] [Related]
9. Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts.
Wang W; Ke S; Wu Q; Charnsangavej C; Gurfinkel M; Gelovani JG; Abbruzzese JL; Sevick-Muraca EM; Li C
Mol Imaging; 2004 Oct; 3(4):343-51. PubMed ID: 15802051
[TBL] [Abstract][Full Text] [Related]
10. RGD-human serum albumin conjugates as efficient tumor targeting probes.
Chen K; Xie J; Chen X
Mol Imaging; 2009; 8(2):65-73. PubMed ID: 19397852
[TBL] [Abstract][Full Text] [Related]
11. Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers.
Wu Y; Cai W; Chen X
Mol Imaging Biol; 2006; 8(4):226-36. PubMed ID: 16791749
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4.
Jin ZH; Furukawa T; Galibert M; Boturyn D; Coll JL; Fukumura T; Saga T; Dumy P; Fujibayashi Y
Nucl Med Biol; 2011 May; 38(4):529-40. PubMed ID: 21531290
[TBL] [Abstract][Full Text] [Related]
13. RGD-labeled USPIO inhibits adhesion and endocytotic activity of alpha v beta3-integrin-expressing glioma cells and only accumulates in the vascular tumor compartment.
Kiessling F; Huppert J; Zhang C; Jayapaul J; Zwick S; Woenne EC; Mueller MM; Zentgraf H; Eisenhut M; Addadi Y; Neeman M; Semmler W
Radiology; 2009 Nov; 253(2):462-9. PubMed ID: 19789239
[TBL] [Abstract][Full Text] [Related]
14. In vivo noninvasive optical imaging of receptor-mediated RGD internalization using self-quenched Cy5-labeled RAFT-c(-RGDfK-)(4).
Jin ZH; Razkin J; Josserand V; Boturyn D; Grichine A; Texier I; Favrot MC; Dumy P; Coll JL
Mol Imaging; 2007; 6(1):43-55. PubMed ID: 17311764
[TBL] [Abstract][Full Text] [Related]
15. Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5).
Zannetti A; Del Vecchio S; Iommelli F; Del Gatto A; De Luca S; Zaccaro L; Papaccioli A; Sommella J; Panico M; Speranza A; Grieco P; Novellino E; Saviano M; Pedone C; Salvatore M
Clin Cancer Res; 2009 Aug; 15(16):5224-33. PubMed ID: 19671851
[TBL] [Abstract][Full Text] [Related]
16. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
17. A new optical imaging probe targeting αVβ3 integrin in glioblastoma xenografts.
Lanzardo S; Conti L; Brioschi C; Bartolomeo MP; Arosio D; Belvisi L; Manzoni L; Maiocchi A; Maisano F; Forni G
Contrast Media Mol Imaging; 2011; 6(6):449-58. PubMed ID: 22144022
[TBL] [Abstract][Full Text] [Related]
18. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.
Chen X; Park R; Shahinian AH; Tohme M; Khankaldyyan V; Bozorgzadeh MH; Bading JR; Moats R; Laug WE; Conti PS
Nucl Med Biol; 2004 Feb; 31(2):179-89. PubMed ID: 15013483
[TBL] [Abstract][Full Text] [Related]
19. Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects.
Kimura RH; Cheng Z; Gambhir SS; Cochran JR
Cancer Res; 2009 Mar; 69(6):2435-42. PubMed ID: 19276378
[TBL] [Abstract][Full Text] [Related]
20. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
